v3.26.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Research and development, net $ (6,283) $ (6,630)
Sales, general and administrative (8,460) (4,995)
Operating loss (14,743) (11,625)
Financing income, net 1,285 182
Other income 316
Net loss $ (13,142) $ (11,443)
Basic net loss per share $ (0.29) $ (0.73)
Diluted net loss per share $ (0.29) $ (0.73)
Basic weighted average common shares outstanding 45,790,362 15,644,511
Diluted weighted average common shares outstanding 45,790,362 15,644,511